GeneDx Holdings Corp.
WGS- Exchange
- Nasdaq
- Industry
- Services-Health Services
- SEC CIK
- 0001818331
In the last 90 days, GeneDx Holdings Corp. insiders filed 0 open-market purchases and 5 sales; 223 institutions reported holding it in 13F filings for Q2 2026, worth $2.17B in total; ARK Invest is the only superinvestor holding it.
Superinvestors holding WGS, Q2 2026
1 superinvestor reports holding GeneDx Holdings Corp. on Form 13F, worth $110.5M in total. Weight is GeneDx Holdings Corp.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| ARK InvestCathie Wood | 0.7% | 1,610,189 | $110.5M | Added+21.6% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of WGS each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
1 superinvestor holding at quarter end
- Added
- ARK Invest (+21.6%)
Q1 2026
1 superinvestor holding at quarter end
- Added
- ARK Invest (+119.1%)
Q4 2025
1 superinvestor holding at quarter end
- Added
- ARK Invest (+35.3%)
Q3 2025
1 superinvestor holding at quarter end
- New
- ARK Invest
Q4 2022
0 superinvestors holding at quarter end
- Sold out
- Third Point
Q2 2022
1 superinvestor holding at quarter end
- Added
- Third Point (+29.1%)
Q1 2022
1 superinvestor holding at quarter end
- Sold out
- Viking Global Investors
Q4 2021
2 superinvestors holding at quarter end
- Added
- Third Point (+53.7%)
- Reduced
- Viking Global Investors (−59.1%)
- Sold out
- ARK Invest
Q3 2021
3 superinvestors holding at quarter end